Showing results (71-80 of 225) with videos related to
Sort By:
Pageof 23
Anticancer Research|February 11, 2014
Treatment of collecting duct carcinoma: current status and future perspectivesGiuseppe Procopio, Isabella Testa, Roberto Iacovelli, et al.Targeted Oncology|July 13, 2016
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate CancerAlessandra Modena, Roberto Iacovelli, Aldo Scarpa, et al.Future Oncology (London, England)|July 11, 2015
Inside the 2015 ASCO Genitourinary Cancers SymposiumMatteo Santoni, Francesco Massari, Roberto Iacovelli, et al.Anticancer Research|August 19, 2007
Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartumAntonio Frega, Paolo Scirpa, Roberto Corosu, et al.Anticancer Research|August 5, 2006
Follow-up of high-grade squamous intra-epithelial lesions (H-SIls) in human immunodeficiency virus (HIV)-positive and human papillomavirus (HPV)-positive women. analysis of risk factorsAntonio Frega, Alberto Biamonti, Luca Maranghi, et al.Cancer Treatment Reviews|August 27, 2018
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysisRoberto Iacovelli, Chiara Ciccarese, Emilio Bria, et al.Critical Reviews in Oncology/Hematology|May 22, 2019
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisionsRoberto Iacovelli, Chiara Ciccarese, Giovanni Schinzari, et al.Cancer Metastasis Reviews|December 17, 2013
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedsideMatteo Santoni, Daniele Santini, Francesco Massari, et al.Critical Reviews in Oncology/Hematology|June 21, 2022
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancersRoberto Iacovelli, Daniela Arduini, Chiara Ciccarese, et al.Prostate Cancer and Prostatic Diseases|November 26, 2022
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicineFilippo Marino, Angelo Totaro, Carlo Gandi, et al.Pageof 23